NYSE:ABTMedical Equipment
Abbott Reworks Nutrition While Targeting Cancer Diagnostics With Exact Sciences Deal
Abbott Laboratories (NYSE:ABT) is pursuing the acquisition of Exact Sciences to expand its presence in cancer diagnostics.
The move comes alongside a targeted turnaround plan for Abbott's Nutrition segment after a recent revenue shortfall.
Management is focusing on pricing actions and new product launches in Nutrition, with an internal goal of segment recovery in the second half of 2026.
Abbott Laboratories, trading at $108.77, is shifting focus toward higher value cancer diagnostics while...